Nurix Therapeutics shares owned by Morgan Stanley
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $25M | 2.2M | 11.39 |
| 2024-12-31 | $30M | 1.6M | 18.84 |
| 2024-09-30 | $42M | 1.9M | 22.47 |
| 2024-06-30 | $42M | 2.0M | 20.87 |
| 2024-03-31 | $37M | 2.5M | 14.70 |
| 2023-12-31 | $32M | 3.1M | 10.32 |
| 2023-09-30 | $2.0M | 253k | 7.86 |
| 2023-06-30 | $2.1M | 209k | 10.00 |
| 2022-12-31 | $4.4M | 400k | 10.97 |
| 2022-06-30 | $9.6M | 582k | 16.53 |
| 2022-03-31 | $9.5M | 681k | 14.01 |
| 2021-06-30 | $12M | 443k | 26.63 |
| 2020-12-31 | $289k | 8.8k | 32.85 |
| 2020-09-30 | $60k | 1.7k | 34.72 |